Welcure Drugs and Pharmaceuticals Ltd.BSE: WELCURE

Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 27 2025

· Issued by Welcure Drugs and Pharmaceuticals Ltd. via BSE India

Filed with BSE · · 1 page · English

Summary by 6ix AI

This filing is an intimation regarding the postponement of a board meeting for Welcure Drugs and Pharmaceuticals Ltd. The meeting was originally scheduled to discuss financial resource augmentation through various methods, including equity shares and convertible instruments. Due to the unavailability of directors, the meeting has been rescheduled to a later date. The company requests that this information be recorded for future reference.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/12/2025 ,inter alia, to consider and approve To augment the financial resources of the Company via funds raising by way of issue of equityshares/convertible instruments/other securities through preferential allotment, right issue, QIP's,ADR GDR, FCCB or any other method or combination thereof, in one or more trenches

Welcure Drugs and Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Welcure Drugs and Pharmaceuticals

Later from Welcure Drugs and Pharmaceuticals

All Welcure Drugs and Pharmaceuticals news releases